Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Surrozen
Sort By
Newest First
Sign in
1 / 1
1 / 1
Bispecific Antibodies
A Small Biotech with Two Complex Bispecific Antibody Candidates Benefits from Lonza’s Blend of Expertise and Flexibility
Craig Parker
PAO-12-21-CL-01
Dec 03, 2021
